Sick sinus syndrome elevates stroke risk in patients with atrial fibrillation with low CHA2DS2-VASC score
Heart Rhythm · 2026
DOI: 10.1016/j.hrthm.2025.11.044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Heart Rhythm, 2026. Verfasst von Sheng-Nan Chang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital Yun-Lin Branch, Yun-Lin, Taiwan. Hauptthemen laut MEDLINE: Atrial Fibrillation, Sick Sinus Syndrome, Stroke. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: National Taiwan University Hospital, National Science and Technology Council.
Themen: Schlaganfall
Abstract (Originalsprache)
BACKGROUND: Atrial fibrillation (AF) and isolated sick sinus syndrome (SSS, without AF) are both associated with increased stroke risk. Although AF and SSS often co-exist as tachy-bradyarrhythmia, the impact of SSS on stroke risk among patients with AF remains unclear. OBJECTIVE: The aim of this study was to evaluate whether SSS is independently associated with incident ischemic stroke in patients with AF. METHODS: We analyzed a hospital-based cohort of 24,960 patients with AF from 2010 to 2021. SSS was defined strictly as symptomatic sinus node dysfunction requiring pacemaker implantation. The primary end point was ischemic stroke hospitalization. Cox models adjusted for CHA2DS2-VASc (congestive heart failure, hypertension, age ≥75 years, diabetes mellitus, stroke or transient ischemic attack, vascular disease, age 65 to 74 years, sex category) score were used to assess associations. RESULTS: Of the 24,960 patients with AF, 1624 had SSS and a pacemaker, whereas 23,336 did not. Patients with SSS were older, more often female, and had higher CHADS2 and CHA2DS2-VASc scores. Over a mean follow-up of 4.07 ± 3.55 years, stroke incidence was 4.02% per patient-year in the SSS group vs 3.03% in the non-SSS group (P 2 (HR 1.02, 95% CI 0.89-1.17, P = .722). CONCLUSION: SSS independently predicts higher stroke risk in patients with AF, particularly among those with lower baseline CHA2DS2-VASc scores. This finding may help refine stroke prevention strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital Yun-Lin Branch, Yun-Lin, Taiwan.
- Division of Cardiology, Department of Internal Medicine, Fu Jen Catholic University Hospital, Fu Jen Catholic University, New Taipei, Taiwan; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan…
- Taichung Municipal Geriatric and Rehabilitation General Hospital, Taichung, Taiwan.
- Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
- Division of Cardiology, Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan.
- Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan. Electronic address: cttsai2022@yahoo.com.
Förderung
- National Taiwan University Hospital
- National Science and Technology Council
Zitieren
APA
Chang, S. N., Huang, P. S., Chen, J. J., Chiu, F. C., Wang, Y. C., Wu, C. K., Wang, C. H., & Tsai, C. T. (2026). Sick sinus syndrome elevates stroke risk in patients with atrial fibrillation with low CHA2DS2-VASC score. Heart Rhythm. https://doi.org/10.1016/j.hrthm.2025.11.044
Vancouver
Chang SN, Huang PS, Chen JJ, Chiu FC, Wang YC, Wu CK, et al. Sick sinus syndrome elevates stroke risk in patients with atrial fibrillation with low CHA2DS2-VASC score. Heart Rhythm. 2026. doi:10.1016/j.hrthm.2025.11.044
BibTeX
@article{Chang2026,
author = {Chang, Sheng-Nan and Huang, Pang-Shuo and Chen, Jien-Jiun and Chiu, Fu-Chun and Wang, Yi-Chih and Wu, Cho-Kai and Wang, Chih-Hsien and Tsai, Chia-Ti},
title = {Sick sinus syndrome elevates stroke risk in patients with atrial fibrillation with low CHA2DS2-VASC score},
journal = {Heart Rhythm},
year = {2026},
doi = {10.1016/j.hrthm.2025.11.044}
}
EUVIMED